These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35886194)

  • 1. Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors.
    Wieteska-Miłek M; Szmit S; Florczyk M; Witowicz A; Kurzyna M
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
    Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
    Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic.
    Wieteska-Miłek M; Szmit S; Florczyk M; Kuśmierczyk-Droszcz B; Ryczek R; Dzienisiewicz M; Torbicki A; Kurzyna M
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.
    Park DH; Fuge J; Meltendorf T; Kahl KG; Richter MJ; Gall H; Ghofrani HA; Kamp JC; Hoeper MM; Olsson KM
    Front Psychiatry; 2021; 12():668647. PubMed ID: 34248706
    [No Abstract]   [Full Text] [Related]  

  • 5. Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension after the Removal of COVID-19 Pandemic Restrictions.
    Wieteska-Miłek M; Witowicz A; Szmit S; Florczyk M; Peller M; Dzienisiewicz M; Kurzyna M
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930062
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
    Charif F; Dakroub F; Bou Akl I; Kularatne M; Montani D
    Respir Med Res; 2023 Nov; 84():101053. PubMed ID: 38236767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension.
    Halimi L; Marin G; Molinari N; Gamez AS; Boissin C; Suehs CM; Vachier I; Bourdin A
    J Psychosom Res; 2018 Feb; 105():45-51. PubMed ID: 29332633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
    Wesley Milks M; Sahay S; Benza RL; Farber HW
    J Heart Lung Transplant; 2021 Mar; 40(3):172-182. PubMed ID: 33414063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension.
    Pathak V; Aris R; Jensen BC; Huang W; Ford HJ
    Lung; 2018 Jun; 196(3):315-319. PubMed ID: 29564533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
    Serati A; Keshmiri MS; Shafaghi S; Mohammad MM; Kashani BS; Naghashzadeh F; Mohamadifar A; Shafaghi M; Noorali S; Hajimoradi M; Astani B; Aghdasi S; Riahi M; Alavi S; Malek R; Movahed MR
    Crit Pathw Cardiol; 2023 Jun; 22(2):60-64. PubMed ID: 37220659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of COVID-19 pandemic on the management of pulmonary hypertension.
    Zhou CY; Sahay S; Shlobin O; Soto FJ; Mathai SC; Melendres-Groves L; Mullin CJ; Levine DJ; Kay D; Highland K; Bossone E; Poms A; Memon H; Balasubramanian V; Farmer MJS; Rahaghi F; Elwing JM
    Respir Med; 2023 Jan; 206():107061. PubMed ID: 36493604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).
    Howard LS; Rosenkranz S; Frantz RP; Hemnes AR; Pfister T; Hsu Schmitz SF; Skåra H; Humbert M; Preston IR
    Chest; 2023 Feb; 163(2):407-418. PubMed ID: 36089068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of musculoskeletal pain and its impact on quality of life and functional exercise capacity in patients with pulmonary arterial hypertension.
    Zeren M; Demir R; Sinan UY; Mustafaoglu R; Yildiz A; Kucukoglu MS
    Respir Med; 2022 Mar; 193():106759. PubMed ID: 35134632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and physical activity level in patients with chronic kidney disease during COVID-19 pandemic.
    Firat M; Vardar-Yagli N; Saglam M; Yildirim T; Erdem Y
    Psychol Health Med; 2023 Mar; 28(3):640-647. PubMed ID: 36128610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of COVID-19 in Patients with Pulmonary Arterial Hypertension.
    Farmakis IT; Giannakoulas G
    Heart Fail Clin; 2023 Jan; 19(1):107-114. PubMed ID: 36435565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical Activity and Symptoms in Pulmonary Arterial Hypertension.
    Matura LA; Shou H; Fritz JS; Smith KA; Vaidya A; Pinder D; Archer-Chicko C; Dubow D; Palevsky HI; Sommers MS; Kawut SM
    Chest; 2016 Jul; 150(1):46-56. PubMed ID: 26892602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individually tailored home-based physiotherapy program makes sustainable improvement in exercise capacity and daily physical activity in patients with pulmonary arterial hypertension.
    Butāne L; Spilva-Ekerte L; Šablinskis M; Skride A; Šmite D
    Ther Adv Respir Dis; 2022; 16():17534666221132477. PubMed ID: 36314474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.
    Lettieri CJ; Nathan SD; Barnett SD; Ahmad S; Shorr AF
    Chest; 2006 Mar; 129(3):746-52. PubMed ID: 16537877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
    Stollfuss B; Richter M; Drömann D; Klose H; Schwaiblmair M; Gruenig E; Ewert R; Kirchner MC; Kleinjung F; Irrgang V; Mueller C
    J Med Internet Res; 2021 Oct; 23(10):e25163. PubMed ID: 34623313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension.
    Pugh ME; Buchowski MS; Robbins IM; Newman JH; Hemnes AR
    Chest; 2012 Dec; 142(6):1391-1398. PubMed ID: 22576635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.